Article
Correlation of genes associated with drug response to prognosis of large cell lung carcinoma.
Chinese journal of cancer - 1 Jul 2011
Chen Cheng, Jiang Xiang-Li, Zhang Cui-Cui, Li Kai
Abstract excerpt
Platinum-based chemotherapy remains the main treatment of advanced lung cancer. However, platinum resistance has become a major treatment obstacle. Novel therapies, particularly tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR-TKI) and agents that target vascular endothelial growth factor (VEGF), have improved the treatment. Both chemotherapy and targeted therapy have their molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
